Latest news for XOMA Royalty (NASDAQ:XOMAP) Stock

XOMA Royalty

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.

XOMA Royalty Corporation - 8.625% Series A Cumulative Perpetual Preferred Stock

XOMA Royalty Corp

Tempus AI Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEM#NASDAQ">TEM</a>) will be reporting its fourth-quarter earnings on Monday. Wall Street expects a loss of 20 cents per share and $203.12 million in revenues as the company reports<a href="https://www.benzinga.com/calendars/earnings?tickers=TEM" target="_blank" rel="noreferrer noopener"> after market hours</a>.
The stock is up over 70% over the past year, 101% YTD.
Let&#8217;s look at what the charts indicate for Tempus AI stock and how the stock currently maps against Wall Street estimates.
Read Also: <a href="https://www.benzinga.com/markets/equities/25/02/43583719/tempus-ai-executives-sell-20-million-in-stock-as-cathie-wood-buys-and-nancy-pelosi-eyes-options">Tempus AI Executives Sell $20 Million In Stock As Cathie Wood Buys And Nancy Pelosi Eyes Options</a>
<h2 class="wp-block-heading">Tempus AI Stock Technicals Mixed Ahead Of Q4 Earnings</h2>
<figure class="wp-block-image size-full"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent022425&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="629" height="489" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/24092903/Screenshot-2025-02-24-at-7.51.07-PM.png" alt="" class="wp-image-795597" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/24092903/Screenshot-2025-02-24-at-7.51.07-PM.png 629w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/24092903/Screenshot-2025-02-24-at-7.51.07-PM-300x233.png 300w" sizes="(max-width: 629px) 100vw, 629px" /></a></figure>
<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent022425&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener">Chart created using Benzinga Pro</a>
Tempus AI stock is showing a mixed technical picture, with a moderately bearish trend and ongoing selling pressure, indicating potential downside risk. The stock, at $69.85, sits well below its eight-day simple moving average of $78.67, a bearish signal suggesting near-term weakness. 
However, the stock remains above its 20-day and 50-day simple moving averages of $68.19 and $50.50, both bullish indicators pointing to underlying support. The 200-day simple moving average is unavailable, but the Moving Average Convergence Divergence (MACD) reading of 7.67 reinforces the bullish outlook, while the Relative Strength Index (RSI) at 54.48 suggests neutral momentum without signaling overbought or oversold conditions. 
For investors, Tempus AI stock appears to be at a crossroads, with short-term bearish pressure but enough technical support to warrant cautious optimism.&nbsp;
<h2 class="wp-block-heading">Tempus AI Analysts See 13.5% Upside</h2>
Ratings &amp; Consensus Estimates:<a href="https://www.benzinga.com/quote/TEM/analyst-ratings" target="_blank" rel="noreferrer noopener"> The consensus analyst rating</a> on Tempus AI stock stands at a Buy currently with a price target of $59.60. TD Cowen, Loop Capital and Needham&#8217;s recent ratings imply a 13.52% downside for Tempus AI stock, with an average $60.67 price target.
TEM Price Action: Tempus AI stock was up 1% at $68.96 at the time of publication Monday.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/02/43805475/big-bets-on-ai-powered-precision-medicine-major-funds-from-ark-and-jpmorgan-to-blackrock-and-citadel-add-tempus-ai-to-their-portfolio">Tempus AI Sees Surge In Institutional Holdings In Q4: Cathie Wood&#8217;s Ark Invest, JPMorgan, And BlackRock Load Up On TEM Stock</a></li>
</ul>
Image created using artificial intelligence via Midjourney.

Technicals

Previews

Tech

Trading Ideas

Tempus AI Gears Up For Q4 Earnings After 101% YTD Surge

RBC Capital analyst Maurice Choy maintains Emera (TSX:<a class="ticker" href="https://www.benzinga.com/stock/EMA#TSX">EMA</a>) with a Outperform and raises the price target from C$60 to C$63.

News

Price Target

Analyst Ratings

TSX:EMA

RBC Capital Maintains Outperform on Emera, Raises Price Target to C$63

LifeSci Capital analyst Jimmy Shan initiates coverage on Tourmaline Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRML#NASDAQ">TRML</a>) with a Outperform rating and announces Price Target of $58.

Initiation

TRML

LifeSci Capital Initiates Coverage On Tourmaline Bio with Outperform Rating, Announces Price Target of $58

RBC Capital analyst Jimmy Shan maintains Boardwalk REIT (TSX:<a class="ticker" href="https://www.benzinga.com/stock/BEI#TSX">BEI</a>) with a Outperform and lowers the price target from C$90 to C$86.

TSX:BEI

TSX:BEI/UN

RBC Capital Maintains Outperform on Boardwalk REIT, Lowers Price Target to C$86

<ul>
<li>Intel launches new Intel&#xAE; Xeon&#xAE; 6 processors with Performance-cores, offering industry-leading performance across data center workloads and up to 2x higher performance in AI processing1.</li>
<li>New Xeon 6 processors for network and edge applications with built-in Intel&#xAE; vRAN Boost deliver up to 2.4x the capacity for radio access network (RAN) workload.&nbsp;</li>
<li>As enterprises modernize infrastructure to meet the demands of next-gen workloads like AI, high-performing and efficient compute is essential across the full spectrum – from data centers to networks, edge and even the PC. To address these challenges, Intel today launched its Xeon 6 processors with Performance-cores (P-cores), providing industry-leading performance for the broadest set of data center and network infrastructure workloads and best-in-class efficiency to create an unmatched server consolidation opportunity.</li>
</ul>

INTC

Intel Launches New Intel® Xeon® 6 Processors With Performance-Cores For AI Processing

Loop Capital analyst Rob Sanderson maintains DoorDash (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DASH#NASDAQ">DASH</a>) with a Buy and raises the price target from $200 to $235.

DASH

Loop Capital Maintains Buy on DoorDash, Raises Price Target to $235

RBC Capital analyst Steven Shemesh maintains Wayfair (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/W#NYSE">W</a>) with a Sector Perform and lowers the price target from $50 to $43.

RBC Capital Maintains Sector Perform on Wayfair, Lowers Price Target to $43

Loop Capital analyst Jeffrey Stevenson maintains Builders FirstSource (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLDR#NYSE">BLDR</a>) with a Buy and lowers the price target from $205 to $190.

BLDR

Loop Capital Maintains Buy on Builders FirstSource, Lowers Price Target to $190

RBC Capital analyst Nik Modi maintains Utz Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UTZ#NYSE">UTZ</a>) with a Outperform and lowers the price target from $23 to $20.

RBC Capital Maintains Outperform on Utz Brands, Lowers Price Target to $20

UBS Gr's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBS#NYSE">UBS</a>) short percent of float has fallen 10.0% since its last report. The company recently reported that it has 5.85 million shares sold short, which is 0.18% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.81 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>UBS Gr Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740412836_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for UBS Gr has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing UBS Gr's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, UBS Gr's peer group average for short interest as a percentage of float is 1.64%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

What Does the Market Think About UBS Gr?

PNC Finl Servs Gr's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PNC#NYSE">PNC</a>) short percent of float has fallen 15.11% since its last report. The company recently reported that it has 4.67 million shares sold short, which is 1.18% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.68 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>PNC Finl Servs Gr Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740412831_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for PNC Finl Servs Gr has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing PNC Finl Servs Gr's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, PNC Finl Servs Gr's peer group average for short interest as a percentage of float is 1.07%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Is The Market Feeling About PNC Finl Servs Gr?

PAR Technology's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAR#NYSE">PAR</a>) short percent of float has risen 5.47% since its last report. The company recently reported that it has 4.34 million shares sold short, which is 13.5% of all regular shares that are available for trading. Based on its trading volume, it would take traders 6.83 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>PAR Technology Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740412825_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for PAR Technology has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing PAR Technology's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, PAR Technology's peer group average for short interest as a percentage of float is 7.38%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Looking Into PAR Technology's Recent Short Interest

Loop Capital analyst Jeffrey Stevenson maintains Boise Cascade (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BCC#NYSE">BCC</a>) with a Buy and lowers the price target from $145 to $140.

Loop Capital Maintains Buy on Boise Cascade, Lowers Price Target to $140

Globus Medical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GMED#NYSE">GMED</a>) has outperformed the market over the past 10 years by 1.79% on an annualized basis producing an average annual return of 12.81%. Currently, Globus Medical has a market capitalization of $11.28 billion. 
Buying $1000 In GMED: If an investor had bought $1000 of GMED stock 10 years ago, it would be worth $3,281.90 today based on a price of $82.00 for GMED at the time of writing.
<h3>Globus Medical's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740412809_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

GMED

Here's How Much You Would Have Made Owning Globus Medical Stock In The Last 10 Years

RBC Capital analyst Ben Hendrix maintains Select Medical Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SEM#NYSE">SEM</a>) with a Outperform and lowers the price target from $47 to $23.

RBC Capital Maintains Outperform on Select Medical Hldgs, Lowers Price Target to $23

Loop Capital analyst Jeffrey Stevenson maintains Louisiana-Pacific (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LPX#NYSE">LPX</a>) with a Hold and lowers the price target from $117 to $110.

Loop Capital Maintains Hold on Louisiana-Pacific, Lowers Price Target to $110

RBC Capital analyst Jonathan Atkin reiterates SBA Comms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBAC#NASDAQ">SBAC</a>) with a Outperform and maintains $255 price target.

Reiteration

SBAC

RBC Capital Reiterates Outperform on SBA Comms, Maintains $255 Price Target

AtlasClear Holdings Inc (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ATCH#AMEX">ATCH</a>) shares are soaring Monday morning on the heels of the company&#8217;s second-quarter financial results. Here&#8217;s what <a href="https://www.benzinga.com/pressreleases/25/02/b43897499/atlasclear-holdings-releases-calendar-year-end-numbers">you need to know</a>.
What Happened: AtlasClear reported second-quarter financial results last week. After the market close on Friday, AtlasClear executives commented on the quarter, suggesting the company&#8217;s shares are undervalued. 
&#8220;We will continue to work to improve our performance, with the hope that it will reflect in our share value,&#8221; said Craig Ridenhour, president of AtlasClear.
&#8220;As we stand today, our current Market Capital is approximately&nbsp;50%&nbsp;of the Net Income earned for the Calendar year on a standalone basis, which we think is value.&#8221;
AtlasClear reported net income of more than $1.75 million for calendar year 2024. The company had a market cap of less than $1 million as of Friday&#8217;s close.
AtlasClear Holdings is considered a low-float stock with just 263,000 shares available for public trading, according to <a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>. Low-float, micro-cap stocks can be extremely volatile, which may help explain some of Monday's massive surge.
ATCH Price Action: <a href="http://benzinga.com/quote/atch">AtlasClear Holdings</a> shares were halted for volatility in early trading Monday morning. The stock was up 401.5% at $11.70 at the time of publication Monday, per <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/technicals/25/02/43915134/riot-stock-q4-earnings-70-percent-upside-or-bearish-breakdown">Riot Stock Stumbles Into Q4 Earnings: 70% Upside Or Bearish Breakdown?</a></li>
</ul>
This illustration was generated using artificial intelligence via Midjourney.

Earnings

Movers

ATCH

What's Going On With AtlasClear Holdings Stock Monday?

Rumors

BLZE

Watching Backblaze; Hearing Zacks Names Stock As A Buy

Shares of Planet Fitness Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLNT#NYSE">PLNT</a>) were rising in early trading on Monday, a day ahead of the company <a href="https://www.benzinga.com/earnings">reporting its fourth-quarter results</a>.
The company's price hikes for new members are likely to be accretive, resulting in a 2.1% upside to the current consensus EBITDA estimate for 2025, according to RBC Capital Markets.
The Planet Fitness Analyst: <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/6645dc02eba8c50001257ef4/logan-reich">Logan Reich</a> maintained an Outperform rating and price target of $120.
The Planet Fitness Thesis: After the company raised the price for its base membership for new members by 50% last year, there has been debate about whether the price hike could more than offset a decline in new members, Reich said in the note.
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
RBC's analysis suggests that the risk of a slowdown in new members is less than what is currently priced in, since only 3.6% of all Planet Fitness' locations face competition from a cheaper competitor within a 1-mile radius, the analyst stated.
"And while 22% of PLNT locations had a cheaper competitor within a 5-mile radius, members typically only drive ~4 miles to a gym on average where driving just 2 miles further would be a 50% increase in driving time," he wrote.
The analysis suggests consensus estimates could be raised by 1.2% for system sales and by 2.1% for EBITDA for 2025, Reich further said.
PLNT Price Action: Shares of Planet Fitness had risen by0.78% to $97.65 at the time of publication on Monday.
Read More: <a href="https://www.benzinga.com/news/25/01/42922091/spacex-apple-airbnb-and-more-companies-pitch-in-to-support-california-residents-after-wildfires-we-want-to-help">SpaceX, Apple, Airbnb And More Companies Pitch In To Support California Residents After Wildfires: &#8216;We Want To Help&#8217;</a>
Photo: Shutterstock

Analyst Color

Long Ideas

PLNT

Planet Fitness 4Q Preview: Price Hikes Could Be Accretive, Says Bullish Analyst

Dividends

Press Releases

XOMA Declares Quarterly Preferred Stock Dividends

XOMA Royalty Reports Second Quarter 2024 Financial Results and Highlights Recent Activities

Health Care

XOMA Royalty to Present at Upcoming Investor Conferences in September

XOMA Royalty Declares Quarterly Preferred Stock Dividends

Zevra's MIPLYFFA™ (arimoclomol) Receives Approval from U.S. Food and Drug Administration for Use in Patients with Niemann-Pick Disease Type C (NPC)

XOMA Royalty Significantly Expands its Royalty and Milestone Portfolio with the Addition of Over 60 Early-Stage Programs from Twist Bioscience

XOMA Royalty Reports Third Quarter 2024 Financial Results and Highlights Recent Activities

XOMA Royalty Acquires Pulmokine for $20 Million Adding the Royalty and Milestone Interest in Seralutinib, a Phase 3 Asset, to Its Portfolio

XOMA Royalty to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference

XOMA

XOMAO

XOMAP

AbbVie

Alnylam Pharmaceuticals, Inc. - Common Stock

Alnylam Pharmaceuticals

Amgen

argenx

Ascendis Pharma A/S - American Depositary Shares

Ascendis Pharma

Biogen

BioMarin Pharmaceutical Inc. - Common Stock

Biomarin Pharmaceutical

BioNTech

Exact Sciences Corporation - Common Stock

Exact Sciences

Exelixis

Gilead Sciences

Genmab

Incyte

Insmed

Moderna

Neurocrine Biosciences, Inc. - Common Stock

Neurocrine Biosciences

Natera

BeiGene, Ltd. - American Depositary Shares

BeiGene

Vaxcyte

Regeneron Pharmaceuticals, Inc. - Common Stock

Regeneron Pharmaceuticals

Roivant Sciences

Revolution Medicines, Inc. - Common Stock

Revolution Medicines

Summit Therapeutics

Sarepta Therapeutics, Inc. - Common Stock

Sarepta Therapeutics

United Therapeutics Corporation - Common Stock

United Therapeutics

Vertex Pharmaceuticals Incorporated - Common Stock

Vertex Pharmaceuticals

XOMA Royalty Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XOMA#NASDAQ">XOMA</a>) ("XOMA" or the "Company") today announced its Board of Directors has authorized the following cash dividends to holders of XOMA's Series A and Series B Cumulative Preferred Stock: &nbsp;Holders of the 8.625% Series A Cumulative Perpetual Preferred Stock (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XOMAP#NASDAQ">XOMAP</a>) shall receive a cash dividend equal to $0.53906 per share.&nbsp;&nbsp;Holders of depositary shares, each representing 1/1000 of a share of XOMA's 8.375% Series B Cumulative Perpetual Preferred Stock (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XOMAO#NASDAQ">XOMAO</a>), shall receive a cash dividend equal to $0.52344 per depositary share.&nbsp;&nbsp;The preferred dividends will be paid on or about October 15, 2024, to respective holders of record at the close of business on October 3, 2024.&nbsp;&nbsp;

Comments

XOMA Royalty

News

Latest news for XOMA Royalty (NASDAQ:XOMAP) Stock

Monday, September 23, 2024

Friday, February 16, 2024

People Also Watch

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga